首页 > 最新文献

BMJ Evidence-Based Medicine最新文献

英文 中文
Patient-reported outcomes and acupuncture-related adverse events are overlooked in acupuncture randomised controlled trials: a cross-sectional meta-epidemiological study. 在针灸随机对照试验中,患者报告的结果和针灸相关不良事件被忽视:一项横断面荟萃流行病学研究。
IF 7.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-03-20 DOI: 10.1136/bmjebm-2024-113497
Yuting Duan, Pinge Zhao, Shujuan Liu, Siqi Wu, Yuening Deng, Zhirui Xu, Xinyu Li, Lin Shi, Yao Wu, Yuejuan Cai, Feng Jiang, Lin Yu

Objectives: To investigate the patient-reported outcomes (PROs) and acupuncture-related adverse events (A-AEs) in acupuncture randomised controlled trials (RCTs).

Design: Cross-sectional meta-epidemiological study.

Data sources: We comprehensively searched for eligible studies between 1 January 2014 and 1 May 2024, in MEDLINE, EMBASE, CENTRAL, CBM, CNKI, Wanfang Data and VIP Database.

Eligibility criteria: RCTs that used acupuncture as the intervention group to obtain the efficacy and/or safety of acupuncture therapy. Acupuncture therapy should be based on Traditional Medicine theory.

Main outcome measures: We assessed (1) the general characteristics of acupuncture RCTs; (2) the general characteristics of PROs; (3) the reporting scores of PROs by the Extension of Consolidated Standards of Reporting Trials of Patient-Reported Outcomes (CONSORT PRO Extension); (4) the general characteristic of A-AEs; (5) the incidence of A-AEs.

Results: We included 476 studies in this study. 296 (62.2%) used PROs as study outcomes, 272 (57.1%) reported safety outcomes. The Visual Analogue Scale (149, 23.7%) and the Pittsburgh Sleep Quality Index (42, 6.7%) were the most common PROs reported. The reporting of PROs was incomplete, with sufficiently reporting scores ranging from 2.7% to 97.6% across the CONSORT PRO Extension. 164 studies reported A-AEs, of which 141 reported specific details, and we found that the OR for the incidence of AEs in the acupuncture group compared to the control group was 1.434 (95% CI 1.148 to 1.793). We identified 1277 reports of A-AEs in eligible studies, predominantly tissue injury (eg, haematoma, bleeding), irritation (eg, pain, post-acupuncture discomfort), with no reports of serious A-AEs. The reporting of A-AEs lacked details on the acquisition methods (15.5%), occurrence time (5.5%), A-AEs' treatment (18.1%) and A-AEs' recovery (19.7%). Studies that reported funding, registry information, acupuncturist qualifications and non-significant primary outcomes were associated with the A-AEs' reporting, and the difference was statistically significant (p≤0.05).

Conclusion: This study found that the reporting of PROs and A-AEs was insufficient in acupuncture RCTs. Future studies should clarify the clinical significance of using PROs as outcomes and report AEs comprehensively to provide patients with sufficient information on the benefits and harms of acupuncture treatments.

目的:探讨针刺随机对照试验(RCTs)中患者报告的转归(PROs)和针灸相关不良事件(a - ae)。设计:横断面荟萃流行病学研究。数据来源:综合检索MEDLINE、EMBASE、CENTRAL、CBM、CNKI、万方数据、VIP数据库,检索2014年1月1日至2024年5月1日符合条件的研究。入选标准:采用针灸作为干预组以获得针灸治疗的有效性和/或安全性的随机对照试验。针灸疗法应以传统医学理论为基础。主要结局指标:我们评估了(1)针灸随机对照试验的一般特征;(2) pro的一般特征;(3)患者报告结局合并试验报告标准扩展版(CONSORT PRO扩展版)的临床试验报告评分;(4) a - ae的一般特性;(5) a - ae的发生率。结果:本研究纳入了476项研究。296例(62.2%)采用PROs作为研究结果,272例(57.1%)报告了安全性结果。视觉模拟量表(149,23.7%)和匹兹堡睡眠质量指数(42,6.7%)是最常见的PROs报告。关于不良事件的报道是不完整的,在CONSORT PRO扩展中,有足够的评分从2.7%到97.6%不等。164项研究报告了a - ae,其中141项报告了具体细节,我们发现针灸组与对照组相比,不良事件发生率的OR为1.434 (95% CI为1.148至1.793)。我们在符合条件的研究中发现了1277例a - ae报告,主要是组织损伤(如血肿、出血)、刺激(如疼痛、针刺后不适),没有严重a - ae的报告。a - ae报告缺乏a - ae获取方法(15.5%)、发生时间(5.5%)、a - ae治疗(18.1%)和a - ae恢复(19.7%)的详细信息。报告资金、注册信息、针灸师资质和无显著性主要结局的研究与a - ae报告相关,差异有统计学意义(p≤0.05)。结论:本研究发现针刺随机对照试验中PROs和a - ae的报道不足。未来的研究应明确使用PROs作为结局的临床意义,并全面报告ae,为患者提供足够的针灸治疗利弊信息。
{"title":"Patient-reported outcomes and acupuncture-related adverse events are overlooked in acupuncture randomised controlled trials: a cross-sectional meta-epidemiological study.","authors":"Yuting Duan, Pinge Zhao, Shujuan Liu, Siqi Wu, Yuening Deng, Zhirui Xu, Xinyu Li, Lin Shi, Yao Wu, Yuejuan Cai, Feng Jiang, Lin Yu","doi":"10.1136/bmjebm-2024-113497","DOIUrl":"10.1136/bmjebm-2024-113497","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the patient-reported outcomes (PROs) and acupuncture-related adverse events (A-AEs) in acupuncture randomised controlled trials (RCTs).</p><p><strong>Design: </strong>Cross-sectional meta-epidemiological study.</p><p><strong>Data sources: </strong>We comprehensively searched for eligible studies between 1 January 2014 and 1 May 2024, in MEDLINE, EMBASE, CENTRAL, CBM, CNKI, Wanfang Data and VIP Database.</p><p><strong>Eligibility criteria: </strong>RCTs that used acupuncture as the intervention group to obtain the efficacy and/or safety of acupuncture therapy. Acupuncture therapy should be based on Traditional Medicine theory.</p><p><strong>Main outcome measures: </strong>We assessed (1) the general characteristics of acupuncture RCTs; (2) the general characteristics of PROs; (3) the reporting scores of PROs by the Extension of Consolidated Standards of Reporting Trials of Patient-Reported Outcomes (CONSORT PRO Extension); (4) the general characteristic of A-AEs; (5) the incidence of A-AEs.</p><p><strong>Results: </strong>We included 476 studies in this study. 296 (62.2%) used PROs as study outcomes, 272 (57.1%) reported safety outcomes. The Visual Analogue Scale (149, 23.7%) and the Pittsburgh Sleep Quality Index (42, 6.7%) were the most common PROs reported. The reporting of PROs was incomplete, with sufficiently reporting scores ranging from 2.7% to 97.6% across the CONSORT PRO Extension. 164 studies reported A-AEs, of which 141 reported specific details, and we found that the OR for the incidence of AEs in the acupuncture group compared to the control group was 1.434 (95% CI 1.148 to 1.793). We identified 1277 reports of A-AEs in eligible studies, predominantly tissue injury (eg, haematoma, bleeding), irritation (eg, pain, post-acupuncture discomfort), with no reports of serious A-AEs. The reporting of A-AEs lacked details on the acquisition methods (15.5%), occurrence time (5.5%), A-AEs' treatment (18.1%) and A-AEs' recovery (19.7%). Studies that reported funding, registry information, acupuncturist qualifications and non-significant primary outcomes were associated with the A-AEs' reporting, and the difference was statistically significant (p≤0.05).</p><p><strong>Conclusion: </strong>This study found that the reporting of PROs and A-AEs was insufficient in acupuncture RCTs. Future studies should clarify the clinical significance of using PROs as outcomes and report AEs comprehensively to provide patients with sufficient information on the benefits and harms of acupuncture treatments.</p>","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"83-92"},"PeriodicalIF":7.6,"publicationDate":"2026-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143973990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is 'minimum' enough? Attending to the 'important' in clinically important differences. “最小”就够了吗?注意“重要”在临床上的重要差异。
IF 7.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-03-20 DOI: 10.1136/bmjebm-2025-114167
Dinne Skjærlund Christensen, David Roe, Helene Speyer
{"title":"Is 'minimum' enough? Attending to the 'important' in clinically important differences.","authors":"Dinne Skjærlund Christensen, David Roe, Helene Speyer","doi":"10.1136/bmjebm-2025-114167","DOIUrl":"10.1136/bmjebm-2025-114167","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"141-142"},"PeriodicalIF":7.6,"publicationDate":"2026-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145032777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FDA approval of benzgalantamine exposes flaws in the 505(b)(2) pathway for innovations on existing drugs. FDA批准苯加兰胺暴露了现有药物创新505(b)(2)途径的缺陷。
IF 7.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-03-02 DOI: 10.1136/bmjebm-2025-114142
Naveen Kumar Reddy, Michael A Steinman, Joseph S Ross, Eric Widera, Nina Zeldes, Robert Steinbrook, Reshma Ramachandran
{"title":"FDA approval of benzgalantamine exposes flaws in the 505(b)(2) pathway for innovations on existing drugs.","authors":"Naveen Kumar Reddy, Michael A Steinman, Joseph S Ross, Eric Widera, Nina Zeldes, Robert Steinbrook, Reshma Ramachandran","doi":"10.1136/bmjebm-2025-114142","DOIUrl":"https://doi.org/10.1136/bmjebm-2025-114142","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":""},"PeriodicalIF":7.6,"publicationDate":"2026-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147343707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing the 'Choosing Wisely' campaign to reduce low-value care in China. 推进“明智选择”运动,减少中国的低价值医疗服务。
IF 7.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-14 DOI: 10.1136/bmjebm-2025-114176
Jay Pan, Wendy Levinson, Xiaolin Wei, Liyong Lu
{"title":"Advancing the 'Choosing Wisely' campaign to reduce low-value care in China.","authors":"Jay Pan, Wendy Levinson, Xiaolin Wei, Liyong Lu","doi":"10.1136/bmjebm-2025-114176","DOIUrl":"https://doi.org/10.1136/bmjebm-2025-114176","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":""},"PeriodicalIF":7.6,"publicationDate":"2026-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146197378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trump's statements about acetaminophen and the problem of epistemic corrections. 特朗普关于扑热息痛的言论和认知纠正问题。
IF 7.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-11 DOI: 10.1136/bmjebm-2025-114372
Federico Germani, Giovanni Spitale, Arthur L Caplan
{"title":"Trump's statements about acetaminophen and the problem of epistemic corrections.","authors":"Federico Germani, Giovanni Spitale, Arthur L Caplan","doi":"10.1136/bmjebm-2025-114372","DOIUrl":"https://doi.org/10.1136/bmjebm-2025-114372","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":""},"PeriodicalIF":7.6,"publicationDate":"2026-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146164059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cluster-randomised controlled trials. 成组随机对照试验。
IF 7.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-11 DOI: 10.1136/bmjebm-2025-114304
Marty Chaplin
{"title":"Cluster-randomised controlled trials.","authors":"Marty Chaplin","doi":"10.1136/bmjebm-2025-114304","DOIUrl":"https://doi.org/10.1136/bmjebm-2025-114304","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":""},"PeriodicalIF":7.6,"publicationDate":"2026-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146163923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapid reviews methods series: practical guidance for conducting timely evidence syntheses. 快速审查方法系列:进行及时证据合成的实用指南。
IF 7.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-21 DOI: 10.1136/bmjebm-2025-114270
Ursula Griebler, Juan Va Franco
{"title":"Rapid reviews methods series: practical guidance for conducting timely evidence syntheses.","authors":"Ursula Griebler, Juan Va Franco","doi":"10.1136/bmjebm-2025-114270","DOIUrl":"10.1136/bmjebm-2025-114270","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"1-2"},"PeriodicalIF":7.6,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145586011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time deficiency: an affliction of healthcare systems and how to ameliorate it. 时间不足:医疗系统的困扰和如何改善它。
IF 7.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-21 DOI: 10.1136/bmjebm-2024-113455
Stephen H Bradley, Victor M Montori
{"title":"Time deficiency: an affliction of healthcare systems and how to ameliorate it.","authors":"Stephen H Bradley, Victor M Montori","doi":"10.1136/bmjebm-2024-113455","DOIUrl":"10.1136/bmjebm-2024-113455","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"71-72"},"PeriodicalIF":7.6,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143959396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to promote the application of reporting guidelines in acupuncture research. 如何促进报告准则在针灸研究中的应用。
IF 7.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-21 DOI: 10.1136/bmjebm-2024-113386
Xiaoyu Liu, Shiyan Yan
{"title":"How to promote the application of reporting guidelines in acupuncture research.","authors":"Xiaoyu Liu, Shiyan Yan","doi":"10.1136/bmjebm-2024-113386","DOIUrl":"10.1136/bmjebm-2024-113386","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"66-70"},"PeriodicalIF":7.6,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144085741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alcohol use and risk of dementia in diverse populations: evidence from cohort, case-control and Mendelian randomisation approaches. 不同人群的酒精使用和痴呆风险:来自队列、病例对照和孟德尔随机化方法的证据
IF 7.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-21 DOI: 10.1136/bmjebm-2025-113913
Anya Topiwala, Daniel F Levey, Hang Zhou, Joseph D Deak, Keyrun Adhikari, Klaus P Ebmeier, Steven Bell, Stephen Burgess, Thomas E Nichols, Michael Gaziano, Murray Stein, Joel Gelernter

Objectives: To investigate the relationship between alcohol consumption and dementia.

Design: Prospective cohort and case-control analyses combined with linear and non-linear Mendelian randomisation.

Setting: Two large-scale population-based cohorts: the US Million Veteran Programme and the UK Biobank. Genetic analyses used summary statistics from genome-wide association studies (GWAS).

Participants: 559 559 adults aged 56-72 years at baseline were included in observational analyses (mean follow-up: 4 years in the US cohort; 12 years in the UK cohort). Genetic analyses used summary data from multiple large GWAS consortia (2.4 million participants).

Main outcome measures: Incident all-cause dementia, determined through health record linkage, and genetic proxies.

Results: During follow-up, 14 540 participants developed dementia and 48 034 died. Observational phenotype-only analyses revealed U-shaped associations between alcohol and dementia risk: higher risk was observed among non-drinkers, heavy drinkers (>40 drinks per week; HR 1.41, 95% CI 1.15 to 1.74), and those with alcohol use disorder (AUD) (HR 1.51, 95% CI 1.42 to 1.60) compared with light drinkers. In contrast, Mendelian randomisation genetic analysis identified a monotonic increase in dementia risk with greater alcohol consumption. A 1 SD increase in log-transformed drinks per week was associated with a 15% dementia increase (inverse-variance weighted (IVW) OR 1.15, 95% CI 1.03 to 1.27). A twofold increase in AUD prevalence was associated with a 16% increase in dementia risk (IVW OR 1.16, 95% CI 1.03 to 1.30). Alcohol intake increased dementia, but individuals who developed dementia also experienced a decline in alcohol intake over time, suggesting reverse causation-where early cognitive decline leads to reduced alcohol consumption-underlies the supposed protective alcohol effects in observational studies.

Conclusions: These findings provide evidence for a relationship between all types of alcohol use and increased dementia risk. While correlational observational data suggested a protective effect of light drinking, this could be in part attributable to reduced drinking seen in early dementia; genetic analyses did not support any protective effect, suggesting that any level of alcohol consumption may contribute to dementia risk. Public health strategies that reduce the prevalence of alcohol use disorder could potentially lower the incidence of dementia by up to 16%.

目的:探讨饮酒与痴呆的关系。设计:前瞻性队列和病例对照分析结合线性和非线性孟德尔随机化。背景:两个大规模的以人口为基础的队列:美国百万退伍军人计划和英国生物银行。遗传分析使用全基因组关联研究(GWAS)的汇总统计数据。559名56-72岁的成年人被纳入观察性分析(美国队列平均随访4年,英国队列平均随访12年)。遗传分析使用了来自多个大型GWAS联盟(240万参与者)的汇总数据。主要结局指标:通过健康记录关联和遗传代理确定的全因痴呆事件。结果:随访期间,14540名参与者出现痴呆,48034人死亡。仅观察性表型分析揭示了酒精与痴呆风险之间的u型关联:与轻度饮酒者相比,不饮酒者、重度饮酒者(每周饮酒40次;风险比1.41,95% CI 1.15至1.74)和酒精使用障碍(AUD)患者(风险比1.51,95% CI 1.42至1.60)的风险更高。相比之下,孟德尔随机化遗传分析发现,饮酒越多,痴呆风险单调增加。每周饮酒1 SD增加与痴呆症增加15%相关(反方差加权(IVW) OR 1.15, 95% CI 1.03至1.27)。AUD患病率增加两倍与痴呆风险增加16%相关(IVW OR 1.16, 95% CI 1.03 - 1.30)。酒精摄入会增加痴呆症,但随着时间的推移,患有痴呆症的个体也会经历酒精摄入量的下降,这表明了反向因果关系——早期认知能力下降导致酒精摄入量减少——这是观察性研究中假定的酒精保护作用的基础。结论:这些发现为所有类型的酒精使用与痴呆风险增加之间的关系提供了证据。虽然相关观察数据表明少量饮酒具有保护作用,但这可能部分归因于早期痴呆症中饮酒减少;基因分析没有支持任何保护作用,这表明任何水平的酒精消费都可能增加痴呆症的风险。减少酒精使用障碍患病率的公共卫生战略可能会将痴呆症的发病率降低多达16%。
{"title":"Alcohol use and risk of dementia in diverse populations: evidence from cohort, case-control and Mendelian randomisation approaches.","authors":"Anya Topiwala, Daniel F Levey, Hang Zhou, Joseph D Deak, Keyrun Adhikari, Klaus P Ebmeier, Steven Bell, Stephen Burgess, Thomas E Nichols, Michael Gaziano, Murray Stein, Joel Gelernter","doi":"10.1136/bmjebm-2025-113913","DOIUrl":"10.1136/bmjebm-2025-113913","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the relationship between alcohol consumption and dementia.</p><p><strong>Design: </strong>Prospective cohort and case-control analyses combined with linear and non-linear Mendelian randomisation.</p><p><strong>Setting: </strong>Two large-scale population-based cohorts: the US Million Veteran Programme and the UK Biobank. Genetic analyses used summary statistics from genome-wide association studies (GWAS).</p><p><strong>Participants: </strong>559 559 adults aged 56-72 years at baseline were included in observational analyses (mean follow-up: 4 years in the US cohort; 12 years in the UK cohort). Genetic analyses used summary data from multiple large GWAS consortia (2.4 million participants).</p><p><strong>Main outcome measures: </strong>Incident all-cause dementia, determined through health record linkage, and genetic proxies.</p><p><strong>Results: </strong>During follow-up, 14 540 participants developed dementia and 48 034 died. Observational phenotype-only analyses revealed U-shaped associations between alcohol and dementia risk: higher risk was observed among non-drinkers, heavy drinkers (>40 drinks per week; HR 1.41, 95% CI 1.15 to 1.74), and those with alcohol use disorder (AUD) (HR 1.51, 95% CI 1.42 to 1.60) compared with light drinkers. In contrast, Mendelian randomisation genetic analysis identified a monotonic increase in dementia risk with greater alcohol consumption. A 1 SD increase in log-transformed drinks per week was associated with a 15% dementia increase (inverse-variance weighted (IVW) OR 1.15, 95% CI 1.03 to 1.27). A twofold increase in AUD prevalence was associated with a 16% increase in dementia risk (IVW OR 1.16, 95% CI 1.03 to 1.30). Alcohol intake increased dementia, but individuals who developed dementia also experienced a decline in alcohol intake over time, suggesting reverse causation-where early cognitive decline leads to reduced alcohol consumption-underlies the supposed protective alcohol effects in observational studies.</p><p><strong>Conclusions: </strong>These findings provide evidence for a relationship between all types of alcohol use and increased dementia risk. While correlational observational data suggested a protective effect of light drinking, this could be in part attributable to reduced drinking seen in early dementia; genetic analyses did not support any protective effect, suggesting that any level of alcohol consumption may contribute to dementia risk. Public health strategies that reduce the prevalence of alcohol use disorder could potentially lower the incidence of dementia by up to 16%.</p>","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"13-22"},"PeriodicalIF":7.6,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7618643/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145129871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMJ Evidence-Based Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1